Targeting neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s Identified two lead cannabinoid analog compounds for in vivo studies NSERC grant funding supports InMed’s collaborative research projects with Dr. Kumar… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has… Read More
VANCOUVER, BC — Thrive Health has been ranked #1 in Deloitte’s 2022 Technology Fast 50 Companies to Watch list. Celebrating its 25th anniversary, the award recognizes emerging companies based on… Read More
VANCOUVER, BC — Virogin Biotech, a clinical-stage biotech company, today announced that the first patient has been dosed in its Phase 1 clinical study evaluating VG201, a first-in-class HSV Type I… Read More
OTTAWA, ON – The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour. Dr…. Read More
